Femoral Fracture
Conditions
Keywords
Femur, Fat, Emboli, Bone, Marrow, proteomic, proteomics, metabolomics, metabolomic, inflammatory, cytokine, chemokine, anaphlylatoxin, Thromboelastography, Medical Center of the Rockies, Fat Embolism Syndrome, Injury, Fracture, Metabolite, MCR, TEG, FES
Brief summary
This is an observational study designed to investigate the role of fat emboli in patients who are undergoing a tibial or femoral fracture procedure in the operating room. The purpose of this study is to obtain samples of bone marrow and blood during tibial or femoral fracture procedures to understand the inflammatory response.
Detailed description
Bone marrow is routinely removed during a tibial or femoral fracture procedure; researchers will take samples for this study from bone marrow that has already been removed as part of this procedure. No additional marrow samples will be taken as part of this research study. Also, researchers will collect blood (about 4 teaspoons) for testing inflammatory response and coagulation. Researchers may need to insert an additional line to collect your blood.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients undergoing a tibial or femoral fracture procedure in the operating room.
Exclusion criteria
* n/a
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Inflammatory Response | One day | Samples will be tested using proteomic and metabolomic assays from samples of bone marrow reamed during intramedullary (IM) femoral nailing. Blood samples drawn at the time of IM nailing will be tested to determine if clinically relevant amounts of marrow containing these inflammatory mediators are released into the bloodstream. |
Countries
United States